-
公开(公告)号：US20110042709A1
公开(公告)日：2011-02-24
申请号：US12857760
申请日：2010-08-17
IPC分类号： H01L33/62
CPC分类号： F21K9/232 , F21Y2115/10
摘要： The current invention introduces a semiconductor light emitting device mounted in a free-standing way for enhanced light extraction and handling simplicity. The free-standing mount is based on the mechanical strength of the current carrying connectors, such as wires or bonds. Such mounted LED die can be placed into standard light bulb body for compatibility with existing household, car, consumer electronics or industrial light sources. The current invention provides increased light extraction efficiency which makes general LED lighting simpler and cheaper. The mounting into a conventional light bulb provides the consumer with the ease of handling and mounting.
摘要翻译： 本发明引入了以独立方式安装的半导体发光器件，用于增强光提取和处理简单性。 独立式安装座基于载流连接器的机械强度，例如电线或接头。 这种安装的LED管芯可以放置在标准的灯泡体中，以与现有的家用，汽车，消费电子产品或工业光源兼容。 本发明提供了增加的光提取效率，这使得一般的LED照明更简单和便宜。 安装到传统的灯泡中为消费者提供了便于处理和安装。
-
公开(公告)号：US09216219B2
公开(公告)日：2015-12-22
申请号：US13912355
申请日：2013-06-07
申请人： Marta Cosenza , Christoph Stark
发明人： Marta Cosenza , Christoph Stark
IPC分类号： C07K16/00 , C07K16/28 , A61K39/395 , A61K9/00 , A61K47/18 , A61K47/26 , C07K14/705 , C07K14/71 , C07K14/715 , A61K39/00
CPC分类号： C07K16/2878 , A61K9/0019 , A61K39/3955 , A61K39/39591 , A61K47/183 , A61K47/26 , A61K2039/505 , C07K16/28 , C07K2317/41 , C07K2317/56 , C07K2317/565 , C07K2317/76
摘要： Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid.
摘要翻译： 配制抗BAFFR抗体作为液体制剂，其包含高浓度的抗体活性成分，用于递送至不具有高水平抗体聚集的患者。 含水药物组合物可以包括一种或多种糖，缓冲剂，表面活性剂和/或游离氨基酸。
-
公开(公告)号：US09751951B2
公开(公告)日：2017-09-05
申请号：US14942388
申请日：2015-11-16
申请人： Marta Cosenza , Christoph Stark
发明人： Marta Cosenza , Christoph Stark
IPC分类号： A61K39/395 , C07K16/28 , A61K9/00 , A61K47/18 , A61K47/26 , C07K14/715 , A61K39/00
CPC分类号： C07K16/2878 , A61K9/0019 , A61K39/3955 , A61K39/39591 , A61K47/183 , A61K47/26 , A61K2039/505 , C07K16/28 , C07K2317/41 , C07K2317/56 , C07K2317/565 , C07K2317/76
摘要： Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid.
-
公开(公告)号：US20130344088A1
公开(公告)日：2013-12-26
申请号：US13912355
申请日：2013-06-07
申请人： Marta Cosenza , Christoph Stark
发明人： Marta Cosenza , Christoph Stark
IPC分类号： A61K39/395
CPC分类号： C07K16/2878 , A61K9/0019 , A61K39/3955 , A61K39/39591 , A61K47/183 , A61K47/26 , A61K2039/505 , C07K16/28 , C07K2317/41 , C07K2317/56 , C07K2317/565 , C07K2317/76
摘要： Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid.
摘要翻译： 配制抗BAFFR抗体作为液体制剂，其包含高浓度的抗体活性成分，用于递送至不具有高水平抗体聚集的患者。 含水药物组合物可以包括一种或多种糖，缓冲剂，表面活性剂和/或游离氨基酸。
-
5.发明申请Composition to be administered to a living being and method for marking agents 审中-公开对生物体施用的组合物和用于标记药剂的方法公开(公告)号：US20060222662A1
公开(公告)日：2006-10-05
申请号：US10546031
申请日：2004-02-17
CPC分类号： C07K14/005 , A61K39/00 , A61K47/646 , A61K47/6901 , A61K2039/5258 , C12N2770/22022
摘要： The invention relates to compositions to be administered to a living being, a method for marking agents that are administered to living beings, the use thereof, and an accelerated test.
摘要翻译： 本发明涉及给予生物体的组合物，对生物施用的标记剂的方法，其用途和加速试验。
-
公开(公告)号：US20160145341A1
公开(公告)日：2016-05-26
申请号：US14942388
申请日：2015-11-16
申请人： Marta Cosenza , Christoph Stark
发明人： Marta Cosenza , Christoph Stark
IPC分类号： C07K16/28
CPC分类号： C07K16/2878 , A61K9/0019 , A61K39/3955 , A61K39/39591 , A61K47/183 , A61K47/26 , A61K2039/505 , C07K16/28 , C07K2317/41 , C07K2317/56 , C07K2317/565 , C07K2317/76
摘要： Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.024 秒)
